Johnson & Johnson

NYSE: JNJ
$162.92
-$1.25 (-0.8%)
Real Time Data Delayed 15 Min.

JNJ Articles

Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September 30, 2011. These public stock holdings have been broken...
Italy and Greece begin efforts to prove that their sovereign debt is safe. (Reuters) Groupon (NASDAQ: GRPN) will make a major holiday effort to drive extra revenue. (Reuters) Appetite for Olympus...
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit...
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The compensation figures are...
Today was a day of red that went to a day of green.  Earnings were at first a disappointment, and producer price index came out far hotter at +0.8% on the headline number before the +0.2% reading if...
Earnings season is upon us and so far things are shaping up either a bit better, or less-bad, than what the news reports and headlines might have led investors to believe. Next week is going to be...
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription writing, and more...
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession....
Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke says the Fed may have to act if inflation falls below targets. (Reuters)...
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Amerisafe, Inc. (NASDAQ: AMSF) named Bear of the Day at...
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month bond.  The participation rate was strong enough that this still shows...
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012. Was Boston...
Moody’s cuts ratings of France’s Credit Agricole and Societe Generale as Greek debt trouble spreads. (Reuters) Federal Reserve may try to help the economy with more bond purchases. (Reuters)...
Obama proposes a $447 billion job stimulation package. (Reuters) Economic problems to be the focus of G7 meetings. (Reuters) One Super Congress member threatens to quit over concerns about military...
A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type of arrhythmia by 21% and lowers bleeding...